Julius Knowles is Director at Keros Therapeutics, Inc. (KROS). They have made 18 open-market trades across 1 company since 2020, most recently 2026-06-04.
CIK 0001808365
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2020, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KROS | 10,958 | $117K |
Shares reported on the most recent Form 4, priced at the 2026-06-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KROS | SELL · 10b5-1 | 2026-06-04 | 2026-06-08 | $10.73 | $28K | +4.6% | +14.1% | +9.1% |
| KROS | SELL | 2022-01-03 | 2022-01-05 | $57.86 | $5.3M | -14.0% | -15.2% | +12.6% |
| KROS | SELL | 2021-12-01 | 2021-12-03 | $54.09 | $5.1M | -3.8% | +9.2% | -8.3% |
| KROS | SELL | 2021-11-01 | 2021-11-03 | $42.11 | $3.9M | +50.1% | +32.1% | +20.3% |
| KROS | SELL | 2021-10-19 | 2021-10-21 | $38.19 | $598K | +11.7% | +57.2% | +26.3% |
| KROS | SELL | 2021-10-14 | 2021-10-18 | $38.53 | $2.0M | +11.9% | +60.5% | +28.0% |
| KROS | SELL | 2021-10-01 | 2021-10-05 | $40.11 | $976K | -0.4% | +35.5% | +51.6% |
| KROS | SELL | 2021-09-27 | 2021-09-29 | $41.17 | $7.8M | -6.3% | +1.0% | +37.2% |
| KROS | SELL | 2021-07-01 | 2021-07-06 | $41.30 | $3.5M | -0.1% | -12.6% | -1.7% |
| KROS | SELL | 2021-06-04 | 2021-06-08 | $49.14 | $1.5M | +4.9% | -20.1% | -35.5% |
| KROS | SELL | 2021-06-01 | 2021-06-03 | $49.61 | $2.6M | +8.7% | -16.3% | -29.9% |
| KROS | SELL | 2021-05-03 | 2021-05-05 | $57.28 | $5.1M | -6.1% | -13.2% | -35.9% |
| KROS | SELL | 2021-04-06 | 2021-04-08 | $58.81 | $1.1M | -1.7% | -20.6% | -35.3% |
| KROS | SELL | 2021-04-01 | 2021-04-05 | $59.73 | $4.3M | +5.9% | -9.2% | -32.8% |
| KROS | SELL | 2021-03-03 | 2021-03-05 | $56.36 | $2.5M | +0.9% | +2.0% | -18.9% |
| KROS | SELL | 2021-03-01 | 2021-03-03 | $60.92 | $2.6M | +11.8% | +6.0% | -9.7% |
| KROS | SELL | 2021-02-16 | 2021-02-18 | $60.92 | $3.1M | -10.8% | -11.5% | -24.1% |
| KROS | SELL | 2021-02-11 | 2021-02-16 | $63.41 | $2.2M | +9.2% | -8.3% | -15.1% |
| KROS | BUY | 2020-04-13 | 2023-01-20 | $20.98 | $25K | +14.9% | +5.7% | -11.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.